Liz

PhD student @viennabiocenter • @MaxPerutzLabs • @Hallacli_Lab | she/her

[Cell Genomics @CellGenomics]

NERINE reveals rare variant associations in gene networks across phenotypes and implicates an SNCA-PRL-LRRK2 subnetwork in Parkinson’s disease https://t.co/Muc7baGIO9

[The Science of Parkinson's @ScienceofPD]

Researchers identify EDC4 & DCP1 as a selective autophagy receptor pair responsible for P-body turnover in the model plant Marchantia polymorpha; Interestingly, this pathway promotes the degradation of #Parkinsons-associated α-synuclein in human cells
https://t.co/NaIBFe5bZz

[Yasin Dagdas @PlantoPhagy]

If you’re enjoying some calm while others are on holiday, here’s a #NEW #preprint to dive into — led by the brilliant @viennabiocenter student @Alibequelous:
👇A quick 🧵+ link:
https://t.co/sNIxsrdr0p

[Vienna BioCenter Scientific Training @TrainingVbc]

Welcome @ElizabethEthier from @Northeastern joined the lab of Erinc Hallacli @MaxPerutzLabs to identify the genetic determinants of alpha-synuclein localization and their implications in
Parkinson’s disease.

[Alvin Christian @_AlvinChristian]

academic job market so bad you have a better chance of becoming the president of Mexico than landing a tenure track job

[Bailey Schultz @bjschul7]

just saw a marathon sign that said, “You didn’t have to run 26.2 miles just to get out of tissue culture,” and honestly i love boston sometimes

[Hallacli Lab @Hallacli_Lab]

We are looking for a PhD student for an exciting project utilizing iPSC-derived neurons to investigate RNA granules in Parkinson’s Disease! If interested, please apply through the Vienna Biocenter call here 👉 https://t.co/qOGFoFjMJr, applications open until April 15th.

[Prof. Eliot Jacobson @EliotJacobson]

Breaking news!
Code FUBAR!!!

Well, today is the day I have to extend the y-axis to accommodate a new record Global sea surface temperature of 21.21C. How is your day going?

[NASA @NASA]

For the first time since the Apollo era, new NASA science instruments and tech demonstrations are operating on the Moon after @Int_Machines' Odysseus lander arrived on the lunar surface: https://t.co/l1VaQujvOZ

The IM-1 mission team expects to receive images in the coming days.

[Dr. James Quinn @TweetwithQuinn]

Delighted to share my first ever 1st author non-review paper published in @asmsnews for their special issue on Neurodegenerative disease research! This was over 3 years of work from my postdoc @ACTRU_MGH @MGHNeurology, so am happy to see it in print!
https://t.co/wESP2CJ59U (1/7)

[Nature Portfolio @NaturePortfolio]

A Review in @NatRevNeurol reviews our current understanding of the mechanisms underlying synaptic degeneration in Alzheimer disease and highlights key questions that still need to be answered. https://t.co/msQ1ApBR9P

[Liz @ElizabethEthier]

@TweetwithQuinn @Northeastern JQ always coming through with the most support 🙌🏻 Any advice or tips are appreciated!!

[@jxf.me (Bluesky) / [email protected] (Mastodon) @jxxf]

Optimist: The glass is ½ full.
Pessimist: The glass is ½ empty.
Excel: The glass is January 2nd.

[Liz @ElizabethEthier]

Thank you James! Feeling very grateful today 🍾👩🏼‍🔬

[Dr. James Quinn @TweetwithQuinn]

Latest paper in the lab, congrats to my fantastic undergraduate @ElizabethEthier who has got her first ever published paper and 2nd author too! Well done to Savannah and Dr. Carlyle too on this great piece of work🧠

[Alzheimer's Clinical & Translational Research Unit @ACTRU_MGH]

Latest paper in @braincomms "Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation" featuring @ElizabethEthier @Neuroproteome & Dr. Carlyle who is now at @KavliOxford @WadeMartinsLab - https://t.co/P9z47V3xEW

[Liz @ElizabethEthier]

@TweetwithQuinn @Proteintech Glad you like it! Almost as cool as my mug🧠

[Liz @ElizabethEthier]

Best. Lab. Ever. Big shoutout to @TweetwithQuinn and the rest of my labmates for making it such a hard goodbye 🥺

[Liz @ElizabethEthier]

@TweetwithQuinn Totally unbiased opinion 😁

[Liz @ElizabethEthier]

Huge congrats to James and the rest of the team!! Highly recommend reading, VGF is pretty cool💫

[Dr. James Quinn @TweetwithQuinn]

Delighted that our @ACTRU_MGH @MGH_RI review is now out in @braincomms! Come learn everything you have ever wanted to know about the neuropeptide "VGF" as a potential biomarker and therapeutic target in neurodegenerative and psychiatric diseases - (1/3) https://t.co/jp6U8YboZa